Hoth Therapeutics, Inc. (HOTH)
NASDAQ: HOTH · Real-Time Price · USD
0.990
-0.003 (-0.27%)
At close: Mar 9, 2026, 4:00 PM EDT
0.970
-0.020 (-2.05%)
After-hours: Mar 9, 2026, 4:18 PM EDT
Hoth Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 15 | 6 | 6 | 10 | 16 | 32 | |
| Market Cap Growth | 85.03% | -7.96% | -38.29% | -35.89% | -50.32% | -49.16% | |
| Enterprise Value | 8 | -2 | -6 | 1 | 1 | 26 | |
| Last Close Price | 0.99 | 0.75 | 1.44 | 7.80 | 16.50 | 59.25 | |
| PB Ratio | 1.82 | 0.84 | 0.66 | 1.98 | 1.60 | 6.86 | |
| P/TBV Ratio | 1.88 | 0.84 | 0.66 | 1.98 | 1.60 | 6.86 | |
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | - | - | - | |
| Net Debt / Equity Ratio | -0.95 | -1.02 | -0.97 | -1.30 | -1.06 | -1.01 | |
| Net Debt / EBITDA Ratio | - | - | - | - | 0.74 | 0.64 | |
| Net Debt / FCF Ratio | 0.81 | 1.00 | 1.09 | 0.71 | 0.86 | 0.77 | |
| Quick Ratio | 7.76 | 8.53 | 13.76 | 4.78 | 12.02 | 15.03 | |
| Current Ratio | 8.81 | 9.20 | 14.96 | 4.85 | 12.19 | 15.32 | |
| Return on Equity (ROE) | -151.13% | -99.75% | -110.59% | -151.59% | -197.05% | -204.44% | |
| Return on Assets (ROA) | -84.46% | -57.19% | -58.47% | -77.95% | -108.62% | -112.98% | |
| Return on Capital Employed (ROCE) | -144.10% | -119.40% | -83.20% | -206.00% | -139.40% | -148.10% | |
| Earnings Yield | -76.98% | -142.15% | -129.51% | -112.12% | -90.48% | -22.60% | |
| FCF Yield | -62.72% | -121.14% | -134.96% | -91.67% | -76.42% | -19.26% | |
| Buyback Yield / Dilution | -108.05% | -87.00% | -184.69% | -34.07% | -80.63% | -34.90% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.